Τίτλος:
Outpatient treatment of pulmonary embolism
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Over the past decade there has been an increasing trend to manage many conditions traditionally treated during a hospital admission as outpatients. Evidence is increasing to support this approach in patients with pulmonary embolism (PE). In this article, we review the current status of outpatient management of confirmed PE and present a pragmatic approach for clinical healthcare settings. © 2020, European Respiratory Society. All rights reserved.
Συγγραφείς:
Bellou, E.
Keramida, E.
Karampinis, I.
Dimakakos, E.
Misthos, P.
Demertzis, P.
Hardavella, G.
Περιοδικό:
Journal of Breath Research
Εκδότης:
European Respiratory Society
Λέξεις-κλειδιά:
acetylsalicylic acid; anticoagulant agent; apixaban; bivalirudin; brain natriuretic peptide; calcifediol; creatinine; cyclosporine; cytochrome P450 3A4; dabigatran; dronedarone; edoxaban; erythromycin; fondaparinux; ketoconazole; mycophenolate mofetil; oxyhemoglobin; pentasaccharide; prednisone; rivaroxaban; tacrolimus; troponin; warfarin, adult; aged; anticoagulant therapy; anticoagulation; area under the curve; atrial fibrillation; breathing rate; cardiovascular mortality; computer assisted tomography; coronary artery disease; creatinine clearance; deep vein thrombosis; diastolic blood pressure; echocardiography; embolectomy; female; follow up; gastrointestinal hemorrhage; health care cost; health care system; heart rate; heparin induced thrombocytopenia; hospital admission; hospital readmission; hospitalization; human; hypertension; immunosuppressive treatment; kidney function; kidney graft; lactation; length of stay; lung embolism; mortality; noninvasive ventilation; obesity; outpatient; oxygen saturation; platelet count; predictive value; pregnancy; recurrent disease; Review; rhesus monkey; risk assessment; risk factor; social support; systolic blood pressure; thrombocytopenia
DOI:
10.1183/20734735.0069-2020
